Chemical Compound
ss-D-Glucopyranoside, (3ss,12ss)-3,12-dihydroxydammar-24-en-20-yl; (3ss,12ss)-3,12-Dihydroxydammar-24-en-20-yl ss-D-glucopyranoside; 20(S)-Protopanaxadiol 20-O-D-glucopyranoside; 20(S)-Protopanaxadiol 20-O-ss-D-glucopyranoside; 20-O-ss-D-Glucopyranosyl-20(S)-protopanaxadiol; 20-O-ss-Glucopyranosyl-20(S)-protopanaxadiol; 3-O-Deglucosylginsenoside F2; Compound k; Ginsenoside C-K; Ginsenoside IH901; Ginsenoside K; Ginsenoside M1; Ginsenoside compound K; Ginsenoside metabolite M1; IH 901; Protopanaxadiol 20-O-glucoside
CAS Registry Number
39262-14-1
Primary record
ss-D-Glucopyranoside, (3ss,12ss)-3,12-dihydroxydammar-24-en-20-yl; (3ss,12ss)-3,12-Dihydroxydammar-24-en-20-yl ss-D-glucopyranoside; 20(S)-Protopanaxadiol 20-O-D-glucopyranoside; 20(S)-Protopanaxadiol 20-O-ss-D-glucopyranoside; 20-O-ss-D-Glucopyranosyl-20(S)-protopanaxadiol; 20-O-ss-Glucopyranosyl-20(S)-protopanaxadiol; 3-O-Deglucosylginsenoside F2; Compound k; Ginsenoside C-K; Ginsenoside IH901; Ginsenoside K; Ginsenoside M1; Ginsenoside compound K; Ginsenoside metabolite M1; IH 901; Protopanaxadiol 20-O-glucoside
- 库存
- 8,799 克
- 纯度
- 99.5 %
- CAS
- 39262-14-1
化合物标识与属性
- CAS
- 39262-14-1
- PubChem CID
- 9852086
- SMILES
- CC(=CCC[C@@](C)([C@H]1CC[C@@]2([C@@H]1[C@@H](C[C@H]3[C@]2(CC[C@@H]4[C@@]3(CC[C@@H](C4(C)C)O)C)C)O)C)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)C
- Canonical SMILES
- CC(C)=CCC[C@](C)(O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O)C(C)(C)[C@@H]3CC[C@]12C
名称与同义词
- ginsenoside C-K
- ginsenoside CK
- Ginsenoside K
- Compound K
- ginsenoside compound K
- ginsenoside M1
- 39262-14-1
- ginsenosideCK
- CompoundK
- GM1 saponin
- CompoundCK
- Compound-K
- ginsenoside-C-K
- Compound CK
- Gisenoside C-K
- 20(S)-Ginsenoside C-K
- 20(S)-GINSENOSIDE CK
- IH901 cpd
- Sg(S)-ginsenoside c-k
- RefChem:639972
- Ginsenoside metabolite M1
- (20S)-ginsenoside C-K
- 3-O-Deglucosylginsenoside F2
- NT3 VAN SC6
- Protopanaxadiol 20-O-glucoside
- CHEMBL3355096
- CHEBI:77146
- UNII-G8D4792Q7K
- MFCD07772261
- G8D4792Q7K
- IH901
- orb1303718
- C36H62O8
- SCHEMBL18179307
- ginsenoside metabolite compound K
- DTXSID60431770
- GLXC-03739
- HY-N0904
- BDBM50023446
- IH 901
- IH-901
- NP6992
- s9105
- ZINC96095535
- AKOS037514664
- Ginsenoside compound K; Ginsenoside K
- 20-O-beta-D-glucopyranosyl-20(S)-protopanaxadiol
- ACN-047164
- CCG-270260
- CID9852086
- CS-3840
- EBC-615548
- MG33283
- CID 9852086
- CID:9852086
- AC-33947
- AS-82692
- DA-63760
- GINSENOSIDE C-K (REFERENCE GRADE)
- SID:53788957
- SID:53789726
- AB0029014
- AB3000007
- J354.006E
- FT-0777135
- G0590
- N1890
- X1141
- 20-O-(beta-D-glucopyranosyl)-20(S)-protopanaxadiol
- C22127
- (2s,3r,4s,5s,6r)-2-[(2s)-2-[(3s,5r,8r,9r,10r,12r,13r,14r,17s)-3,12-dihydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-17-yl]-6-methylhept-5-en-2-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol
- 20-O-beta-Glucopyranosyl-20(S)-protopanaxadiol
- (20S)-20-(beta-D-Glucopyranosyloxy)dammara-24-ene-3beta,12beta-diol
- (20S)-20-O-beta-D-Glucopyranosylprotopanaxadiol
- 262S141
- A873672
- C112772
- C482402
- BRD-K01942833-001-01-8
- Q27146701
- (2S,3R,4S,5S,6R)-2-{[(2S)-2-[(1S,3aR,3bR,5aR,7S,9aR,9bR,11R,11aR)-7,11-dihydroxy-3a,3b,6,6,9a-pentamethyl-hexadecahydro-1H-cyclopenta[a]phenanthren-1-yl]-6-methylhept-5-en-2-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
- 20-(beta-D-glucopyranosyloxy)dammar-24-ene-3beta,12-diol
- (3beta,12beta)-3,12-dihydroxydammar-24-en-20-yl beta-D-glucopyranoside
- 20(S)-PROTOPANAXADIOL 20-O-.BETA.-D-GLUCOPYRANOSIDE
- 20-(beta-D-Glucopyranosyloxy)dammar-24-ene-3beta,12beta-diol
- 20beta-(beta-D-glucopyranosyloxy)dammar-24-ene-3beta,12beta-diol
- 3beta,12beta-Dihydroxydammara-24-ene-20-yl beta-D-glucopyranoside
- (20R)-3beta,12beta-Dihydroxydammar-24-en-20-yl beta-D-glucopyranoside
- (20S)-20-(beta-D-Glucopyranosyloxy)-3beta,12beta-dihydroxydammara-24-ene
- 20-(beta-D-Glucopyranosyloxy)-5alpha-dammara-24-ene-3beta,12beta-diol
- 3beta,12beta-Dihydroxy-5alpha-dammara-24-ene-20-yl beta-D-glucopyranoside
- (20S)-20-(beta-D-Glucopyranosyloxy)-5alpha-dammara-24-ene-3beta,12beta-diol
- (3.BETA.,12.BETA.)-3,12-DIHYDROXYDAMMAR-24-EN-20-YL .BETA.-D-GLUCOPYRANOSIDE
- .BETA.-D-GLUCOPYRANOSIDE, (3.BETA.,12.BETA.)-3,12-DIHYDROXYDAMMAR-24-EN-20-YL
- (2S,3R,4S,5S,6R)-2-[(1S)-1-[(3S,5R,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-1,5-dimethyl-hex-4-enoxy]-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol
- ss-D-Glucopyranoside, (3ss,12ss)-3,12-dihydroxydammar-24-en-20-yl; (3ss,12ss)-3,12-Dihydroxydammar-24-en-20-yl ss-D-glucopyranoside; 20(S)-Protopanaxadiol 20-O-D-glucopyranoside; 20(S)-Protopanaxadiol 20-O-ss-D-glucopyranoside; 20-O-ss-D-Glucopyranosyl-20(S)-protopanaxadiol; 20-O-ss-Glucopyranosyl-20(S)-protopanaxadiol; 3-O-Deglucosylginsenoside F2; Compound k; Ginsenoside C-K; Ginsenoside IH901; Ginsenoside K; Ginsenoside M1; Ginsenoside compound K; Ginsenoside metabolite M1; IH 901; Protopanaxadiol 20-O-glucoside